Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00267293 · ClinicalTrials.gov registry record · Phase 4

Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever

A Phase 4 study of Fever, sponsored by Penn State University.

Completed
Registry status
Phase 4
Development phase
60
Enrollment target
1
Study location

NCT00267293: Completed Phase 4 study of Fever, sponsored by Penn State University.

NCT00267293 is a Phase 4 study of Fever that has completed, run by Penn State University. The registered enrollment target is 60 participants, below the 596-participant average among 18 other Fever trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00267293, a Phase 4 study of Fever, has completed, sponsored by Penn State University.

COMPLETED
Registry status
Phase 4
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Currently, when a child has fever either ibuprofen (e.g. Motrin, Advil) or acetaminophen (e.g. Tylenol) is given. Both Ibuprofen and Acetaminophen are approved for over the counter use for treatment of fever by the Food and Drug Administration (FDA). This study hopes to determine whether giving both medications together is better than giving one medication alone for the treatment of fever.

Primary Outcome

Temperature was measured hourly using a temporal thermometer to monitor the child's temperature in degrees C. Temperature of 38 degrees C or higher was considered febrile.

Conditions Studied

Interventions

  • DRUG Acetaminophen
  • DRUG Ibuprofen

Study Locations (1)

Pennsylvania

  • Penn State Milton S. Hershey Medical Center - Hershey

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2006-01
Est. Completion 2009-06
Phase Phase 4
Penn State University

219 total trials

What the finished NCT00267293 record still lists

NCT00267293 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 596-participant average among 18 other Fever trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Fever appearing as the primary indexed condition, and to 2 interventions - of which Acetaminophen is the first listed.

NCT00267293 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00267293 about?

NCT00267293 is a clinical study titled "Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever". Currently, when a child has fever either ibuprofen (e.g. Motrin, Advil) or acetaminophen (e.g. Tylenol) is given. Both Ibuprofen and Acetaminophen are approved for over the counter use for treatment of fever by the Food and Drug Administration (FDA). This study hopes to determine whether giving both...

What is the current status of trial NCT00267293?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2006-01. Estimated completion is 2009-06.

What conditions does trial NCT00267293 study?

This clinical trial studies the following conditions: Fever.

What interventions are being tested in trial NCT00267293?

The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG).

Who is sponsoring clinical trial NCT00267293?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00267293 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fever

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00267293's enrollment target sits among peer trials

60 14th of 18 higher than 4 of 18 other Fever trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Fever trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00267293, the US trial registry maintained by the National Library of Medicine. NCT00267293 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.